View drug registration information details.
| Items | Registration information |
|---|
| ID | 2889 |
|---|
| No | 2889 |
|---|
| Brand Name | UNICONTIN 400 |
|---|
| Ingredients | THEOPHYLLINE BP 400 MG |
|---|
| Dosage Form | CONTROLLED RELEASE TABLET |
|---|
| Primary Packaging | PVDC-ALU STRIP |
|---|
| Storage | |
|---|
| Shelf Life | 36 MONTHS |
|---|
| Pack Size | BOX OF 3 x 10's AND 10 X10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF SYMPTOMS AND PROPHYLAXIS OF REVERSIBLE BRONCHOSPASM ASSOCIATED WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE, ROUND, FLAT, BEVELLED EDGES, SCORED UNCOATED, TABLETS ENGRAVED WITH "MM" LOGO ON ONE OF THE FACETS AND " U/400" ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | VIMPEX (LAO) CO.,LTD |
|---|
| Manufacturer | MODI - MUNDIPHARMA PRIVATE LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 I 4134/16 |
|---|
| FDD Registration Date | 23-AUG-2022 |
|---|
| Expiry Date | 22-AUG-2025 |
|---|
Back to drug list
|
